FDA Approved: MEPRON — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a supplemental application for Mepron (atovaquone) from GlaxoSmithKline LLC, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• MEPRON (ATOVAQUONE)

Snippet

SUPPL AP for MEPRON (ATOVAQUONE)